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ORIGINAL INVESTIGATION
Risk Factors for Delirium at Discharge
Development and Validation of a Predictive Model
Sharon K. Inouye, MD, MPH; Ying Zhang, MD, MPH; Richard N. Jones, ScD; Dan K. Kiely, MPH, MA;
Frances Yang, PhD; Edward R. Marcantonio, MD, SM
Background: Persistent delirium at the time of hospi-
tal discharge is associated with poor outcomes. The ob-
jectives of this study were to develop and validate a pre-
dictivemodel for persistent delirium at hospital discharge.
Methods: This study followed a prospective validation
design. For the development cohort, 491 consecutive pa-
tients 70 years or older admitted to the hospital without
delirium and surviving to discharge were enrolled from
the general medical units of an academic teaching hos-
pital. For the validation cohort, 461 comparable sub-
jects were enrolled. Twenty-two candidate risk factors
were examined, including 12 baseline factors (present on
admission) and 10 precipitating factors (hospital re-
lated). The primary outcomewas delirium at hospital dis-
charge, measured by the Confusion AssessmentMethod.
Results: Delirium at discharge was present in 58 pa-
tients (11.8%) in the development cohort. Five indepen-
dent risk factors for delirium at discharge were identi-
fied: dementia (odds ratio [OR], 2.3; 95% confidence
interval [CI], 1.4-3.7); vision impairment (OR, 2.1; 95%
CI, 1.3-3.2); functional impairment (OR, 1.7; 95% CI,
1.2-3.0); high comorbidity (OR, 1.7; 95% CI, 1.1-2.6);
and use of physical restraints during delirium (OR, 3.2;
95% CI, 1.9-5.2). A risk stratification system was cre-
ated by adding 1 point for each factor present. Rates of
delirium for the low-risk (0-1 factors), intermediate-
risk (2-3 factors), and high-risk (4-5 factors) groupswere
4%, 18%, and 63%, respectively (P .001). The corre-
sponding rates in the validation cohort, where 28 pa-
tients (6.1%) had delirium at discharge, were 3%, 14%,
and 27% (P .001).
Conclusions: A predictive model based on 5 risk
factors has been successfully validated for prediction of
delirium at discharge in hospitalized older patients. At
least 4 of these risk factors are amenable to intervention
strategies.
Arch Intern Med. 2007;167(13):1406-1413
D ELIRIUM REPRESENTS Acommon, serious, andpotentially preventableproblem for older per-sons.1 Previous work has
emphasized its transient nature; how-
ever, recent studies document that up
to 50% of delirium persists until hospital
discharge and often formonths beyond.2-8
Persistent delirium has been associated
with worse long-term cognitive and
functional outcomes than resolved de-
lirium.6,9 Delirium may be more persis-
tent in persons with underlying demen-
tia.4,6,8,10 Moreover, several precipitating
factors for delirium may not be com-
pletely reversible (eg, those resulting in
neuronal injury).11 Many experts believe
that persistent deliriummay directly con-
tribute to dementia.11-13 Thus, understand-
ing factors that lead to persistent de-
liriumwill help to clarify the pathways by
which delirium may lead to long-lasting
cognitive sequelae.
Patients discharged with delirium rep-
resent a particularly high-risk group. Hos-
pital discharge has been recognized as a
high-risk transition period.14,15 In previ-
ous studies, 49% of older patients expe-
rienced at least 1medical error during tran-
sitions from the hospital,16,17 and 13% to
25% had serious complications.18 De-
lirium is reported in only 3% to 16% of
documented cases at discharge,19-21 andun-
recognized delirium is associatedwith high
mortality. Patients with delirium at dis-
charge from the emergency department22
had a 7-fold increasedmortality risk, with
the highest risk in the unrecognized de-
lirium group. Delirium at discharge was
also associated with a 2.6-fold increased
risk of death or nursing home place-
ment.23 Finally, delirium that persisted be-
yond discharge from acute care was asso-
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ciatedwith rehospitalization,prolonged institutionalization,
and death.24
Our research group has previously examined predis-
posing factors (at admission)25 and precipitating factors
(during hospitalization)26 for delirium. Our goal in the
present study is to extend this work to examine persis-
tence factors leading to delirium that persists until
discharge. This work appears justified given that hospi-
tal discharge represents a transition to a less supervised
environment, that delirium at discharge is associated
with high morbidity and mortality, and that new inter-
ventions may be necessary to improve the transition
period.
Specific objectives of the present studywere to (1) iden-
tify risk factors for delirium at discharge, including base-
line vulnerability factors and hospital-related factors;
(2) develop a predictive model for delirium at discharge
in an initial cohort; and (3) validate the model in an
independent cohort. Our hypotheses were that baseline
factors (eg, comorbidity) and precipitating factors (eg,
iatrogenic events) would be associated with a higher risk
of delirium at discharge. We further hypothesized that
risk factors would differ between those contributing to
delirium that resolves vs those contributing to persis-
tent delirium. Our goals were to develop a predictive
model that would help to identify patients at high risk
for delirium at discharge for enrollment in intervention
programs and to target appropriate interventions
toward the identified risk factors for delirium at
discharge.
METHODS
The study followed a prospective validation design. The pre-
dictive model was first developed in an initial cohort, then ex-
ternally validated in a separate validation cohort.27,28
MODEL DEVELOPMENT
Study Sample
Potential participants were patients aged 70 years or older who
were consecutively admitted to 6 general medicine units (non-
intensive care) at Yale New Haven Hospital with no evidence
of delirium. The sample of 525 patients has been described in
detail previously.29,30 Of the 525 patients, 34 died during hos-
pitalization and were excluded, yielding a final sample of 491
participants.
Study Procedures
Experienced clinical interviewers, whowere blinded to the study
hypotheses, conducted structured interviews with the pa-
tients and their nurses from admission until discharge. The base-
line evaluation completed within 48 hours of admission in-
cluded demographic information and the Mini-Mental State
Examination31; Digit SpanTest32; ConfusionAssessmentMethod
(CAM) rating33; activities of daily living (ADL)34 and instru-
mental ADL35 screening referent to the 2 weeks prior to hos-
pitalization; the Jaeger36 test for vision andwhisper test for hear-
ing37; and the Geriatric Depression Scale (GDS).38 Trained
abstractors reviewed hospital records for diagnoses, labora-
tory results, medications, length of stay, and discharge desti-
nation; they also determined theAPACHE II score (Acute Physi-
ology and Chronic Health Evaluation II)39,40 and Charlson
Comorbidity Index.41 A family member was interviewed to rate
the modified Blessed Dementia Rating Scale.42,43 Subse-
quently, patients were evaluated every other day with theMini-
Mental State Examination, Digit Span Test, and CAM, and di-
rectly observed for the use of physical restraints and bladder
catheters.
Informed consent for study participationwas obtained from
the patients or, for those with substantial cognitive impair-
ment, from a proxy (closest relative or legal guardian), accord-
ing to procedures approved by the institutional review board
of Yale University School of Medicine.
Outcomes
The primary outcome was delirium at hospital discharge. This
was defined as meeting the full validated CAM criteria for de-
lirium33 during hospitalization, then continuing tomeet full or
partial CAM criteria at discharge. The full CAM criteria for de-
lirium required the presence of acute onset and fluctuating
course, inattention, and either disorganized thinking or al-
tered level of consciousness. These criteria have a sensitivity
of 94% to 100% and specificity of 90% to 95% compared with
geropsychiatrists’ ratings and high interrater reliability.31 Par-
tial CAM criteria were defined as the presence of any 1 of the
full CAM criteria, a definition used previously.7,23,24,44,45 Re-
solved delirium was defined as delirium that developed dur-
ing hospitalization but resolved before discharge. The CAMhas
been used to measure changes or resolution in delirium
symptoms.9,46-49
Definition of Variables
We chose cut points based on previous studies, data distribu-
tions, and clinical sensibility. Advanced age was defined as 85
years or older, representing the highest quartile in the sample.
Male sex has been identified as a risk factor previously.25,50 The
cut point of greater than 1 ADL impairment was chosen as the
highest quartile in the sample. Vision impairment was defined
as corrected near vision worse than 20/70 OU.25 A Mini-
Mental State Examination score lower than 24 was used as our
cut point.31 Dementia was defined by either a medical record
diagnosis or modified Blessed Dementia Rating Scale score of
4 or higher.42,51 An APACHE II score higher than 16 or nurse
rating of “severe” was used to identify high severity of ill-
ness.25 A Charlson score of 4 or higher was chosen as the high-
est quartile in the sample.41 A ratio greater than 18 of serum
urea nitrogen to creatinine and albumin levels of 3.5 g/dL or
lower were our cut points, as used previously.25,40,51-53 The num-
ber of iatrogenic events was defined by standard criteria26,54,55
and analyzed as a continuous variable, and the cut point ofmore
than 4 events was used, representing the highest quartile. The
cut points of more than 3 medications newly added in 1 day
and more than 3 psychoactive medications received in 1 day
were used, as previously.26 Delirium-related variables (eg, se-
verity and/or duration) were not included because they could
be determined only in delirious patients.
MODEL VALIDATION
Study Sample
This prospective cohort comprised the control arm of the De-
lirium Prevention Trial, described previously.23,46 Potential par-
ticipants were patients 70 years or older who were consecu-
tively admitted to the general medicine service (nonintensive
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care) at Yale New Haven Hospital with no evidence of de-
lirium but who were at intermediate or high baseline delirium
risk.25We used the entire sample of 469 control patients, which
included 426 matched and 43 unmatched patients. We ex-
cluded 8 patients who died during hospitalization, yielding a
final sample of 461 participants.
Study Procedures
The clinical evaluations, outcomes, and definitions of vari-
ables were identical to those used in the development study.
The only difference was that delirium assessments were con-
ducted daily. The same research staff conducted the study using
the same data-collection instruments, blinded to the study
hypotheses.
STATISTICAL ANALYSES
Baseline characteristics of the development and validation co-
horts were compared using t test statistics for continuous vari-
ables or 2 statistics for categorical variables.
For bivariable and multivariable analyses, delirium at dis-
charge represented the highest level of a 3-level outcome, which
is ordinal and progressive: (1) no delirium; (2) resolved de-
lirium; and (3) delirium at discharge. The ordinal nature is re-
flected by the increasing disease severity across categories; the
progressive nature is demonstrated by the need to pass through
each level to arrive at the next. All analyses were conducted
using the continuation ratio model, a log-binomial regression
model suited to progressive ordinal outcomes.56-59 These mod-
els allowed us to explore whether risk factors that contribute
to delirium that resolves are different from those that contrib-
ute to its persistence. Adjusted odds ratios (ORs) and confi-
dence intervals (CIs) were calculated from the parameter es-
timates and standard errors. For the overall model, the at-risk
period for defining risk factors was considered as the delirium
interval (ie, the total inclusive days of delirium from first day
of a CAM-positive rating until discharge) for the delirium at
discharge group, the period from delirium onset to resolution
in the resolved delirium group, and the entire hospitalization
for the no delirium group.
Initially, bivariable continuation ratio models were con-
ducted, which generated ORs for 3 comparisons—any de-
lirium vs no delirium, delirium at discharge vs resolved de-
lirium, and anoverall comparison yielding anoverall (combined)
OR. For the overall model, an interaction term was included
that tested for significant differences between the first 2 com-
parisons. If the interaction term was not significant, then the
overall OR was not significantly different across the 2 com-
parisons and a single OR was used to describe the likelihood
of developing either outcome.
Potential risk factors were narrowed along axes using the fol-
lowing criteria: (1) prevalence of at least 5% for discrete vari-
ables; (2) relative risk of 1.3 or higher for delirium at discharge
in bivariable analyses (or a statistically significant parameter es-
timate at P=.10 for continuous variables); and (3) clinical rel-
evance. All of the variables measured continuously were consid-
ered as continuous variables in the original selection process. In
addition, multiple cut points were considered for these vari-
ables, selected based on clinical considerations and data distri-
butions. Selection of the final cut point (vs continuous)was based
on fulfillment of our a priori selection criteria. For potentially col-
linear variables, 1 variable was chosen based on its relative risk
and clinical relevance. This axis approach to variable reduction
has been well described.25,26,28,60
Additional analyses were conducted to more fully examine
specific hospital-related factors, namely medications and re-
straints. For these analyses, we conducted nested case-control
studies to more fully control for differing exposure periods in
the study groups.We constrained the exposure period bymatch-
ing on delirium duration in the cases and length of stay in non-
delirious controls. In addition, we further limited the expo-
sure window to the first 3 days after delirium onset for the 2
delirium groups and 3 consecutive days selected randomly for
those without delirium.
The predictive model for delirium created in the develop-
ment cohort was subsequently tested in the validation cohort.
Performance of the predictive model was assessed using the C
statistic, approximating the area under a receiver-operating char-
acteristic curve,61 and ranging from0.5 (no discrimination above
chance) to 1.0 (perfect discrimination). Overall2 andCochran-
Armitage trend tests were used to compare rates of delirium at
discharge by risk strata in both cohorts. All analyses were con-
ducted using SAS version 9.1 (SAS Institute, Cary, North
Carolina).
RESULTS
Baseline characteristics of the development cohort are
summarized in Table1. Of the 491 patients, 106 (21.6%)
developed delirium during hospitalization, and median
length of stay was 9 days (range, 3-67 days). Of the 58
patients with delirium at discharge (11.8%),median time
from admission to delirium onset was 3 days (range, 2-20
days); median duration of delirium in the hospital was 7
days (range, 1-61 days); and median length of stay was
10 days (range, 3-67 days). Of the 48 patients with re-
solved delirium, median time from admission to de-
lirium onset was 4 days (range, 1-21 days); median du-
ration of delirium in the hospital was 5 days (range, 1-64
days); andmedian length of staywas 15 days (range, 3-67
Table 1. Baseline Patient Characteristics in the 2 Cohortsa
Characteristic
Cohort
Developmentb
(n = 491)
Validationc
(n = 461)
Age, yd 79.1 ± 6.1 80.0 ± 6.5
Men 211 (43) 182 (39)
Education, y 11.3 ± 3.5 11.1 ± 3.7
Marriedd 229 (47) 159 (34)
ADL score (range, 0-7) 0.9 ± 1.8 1.0 ± 1.7
Any impairment 152 (31) 161 (35)
Impairment 1 97 (20) 105 (23)
Vision impairmentd 189 (38) 107 (23)
MMSE score 23.1 ± 6.3 23.2 ± 4.9
Score 24d 187 (39) 210 (46)
Dementia 96 (20) 91 (20)
APACHE II scored 14.6 ± 3.5 15.6 ± 4.1
Charlson score41 2.7 ± 2.1 2.7 ± 2.2
Score 4 140 (29) 136 (30)
Abbreviations: ADL, activities of daily living34,35; APACHE II, Acute
Physiology and Chronic Health Evaluation II39,40; MMSE, Mini-Mental State
Examination.31
aData are reported as mean ± SD values or number (percentage) of
subjects.
b In the development cohort, education data were missing for 19 subjects;
Mini-Mental State Examination score, 6 subjects; APACHE II score,
5 subjects; and Charlson score, 1 subject.
c In the validation cohort, education data were missing for 3 subjects.
dP .05, comparing development and validation groups.
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days). Hospital mortality rates in the 3 groups were 22%
in delirium at discharge, 17% in delirium resolved, and
2% in no delirium groups.
DEVELOPMENT OF THE PREDICTIVE MODEL
The 22 candidate risk factor variables considered for the
predictivemodel are listed in Table2, including 12 base-
line (admission) and 10 precipitating (hospital-related)
factors. Using the a priori selection criteria, these vari-
ables were narrowed along the 2 axes. Five independent
factors were selected for inclusion in the final predictive
model (Table3): dementia, vision impairment, ADL im-
pairment, high comorbidity, and restraint use during de-
lirium. These factors were entered into a single model
to provide an overall estimate of the independent con-
tribution of each variable to the persistence of delirium
until discharge. The nested case-control analyses ofmedi-
cations and restraints did not yield any additional vari-
ables for the model.
PERFORMANCE OF THE PREDICTIVE MODEL
Development Cohort
In the development cohort, the final predictivemodel gen-
erated a C statistic of 0.80, indicating good prediction
above chance.61 A risk stratification system was created
by assigning 1 point to each of the final risk factors. Three
risk groups were created: a low-risk group (0-1 factors),
intermediate-risk group (2-3 factors), and high-risk group
(4-5 factors). Rates of deliriumat discharge increased from
4% to 18% to 63% in the low-, intermediate-, and high-
risk groups, respectively (2=87.64 for trend, P .001),
Table 2. Potential Risk Factors for Delirium at Discharge in the Development Cohorta
Potential Risk Factor
Distribution of Risk Factorb
Odds Ratio (95% Confidence Interval)
Delirium at
Discharge
Resolved
Delirium
No
Delirium
Overall
Model
(n = 491)
Any Delirium vs
No Delirium
(n = 491)
Delirium at Discharge
vs Resolved Delirium
(n = 106)
Axis 1 Baseline Risk Factors
Demographics
Age85 y 22 (37.9) 15 (31.3) 60 (15.6) 2.4 (1.6-3.6) 2.9 (1.8-4.7) 1.3 (0.6-3.0)
Male sex 22 (37.9) 19 (39.6) 170 (44.2) 0.8 (0.6-1.2) 0.8 (0.5-1.2) 0.9 (0.4-2.0)
Education, y 10.5 ± 3.3 10.2 ± 3.9 11.6 ± 3.4 0.9 (0.9-1.0) 0.9 (0.9-1.0) 1.0 (0.9-1.2)
Physical functioning
ADL impairment1 26 (44.8) 15 (31.3) 56 (14.5) 3.1 (2.0-4.7) 3.7 (2.3-6.0) 1.8 (0.8-4.0)
Vision impairment 43 (74.1) 26 (54.2) 120 (31.2) 3.6 (2.5-5.4) 4.1 (2.6-6.5) 2.4 (1.1-5.5)
Cognitive functioning
MMSE score24 41 (74.5) 30 (63.8) 116 (30.3) 4.1 (2.7-6.1)c 5.3 (3.3-8.5) 1.7 (0.7-3.9)
Dementia, by diagnosis or mBDRS score4 34 (58.6) 14 (29.2) 48 (12.5) 5.1 (3.3-7.7) 5.8 (3.6-9.5) 3.4 (1.5-7.8)
Biomedical
APACHE II score16 or nurse rating of severe 23 (39.7) 16 (33.3) 96 (24.9) 1.6 (1.1-2.4) 1.8 (1.1-2.8) 1.3 (0.6-2.9)
Charlson score414 25 (43.1) 16 (33.3) 99 (25.7) 1.7 (1.2-2.6) 1.8 (1.2-2.9) 1.5 (0.7-3.4)
SUN-Cr ratio18 39 (67.2) 23 (48.9) 182 (47.3) 1.7 (1.2-2.5) 1.6 (1.0-2.5) 2.1 (1.0-4.7)
Albumin3.5 g/dL 19 (32.8) 17 (35.4) 69 (17.9) 1.8 (1.2-2.8)c 2.4 (1.5-3.8) 0.9 (0.4-2.0)
Axis 2 Hospital-Related Factorsd
Immobilization
Restraint use 30 (51.7) 12 (25.0) 33 (8.6) 5.7 (3.6-8.9) 7.0 (4.1-11.9) 3.2 (1.4-7.4)
Catheter use 30 (51.7) 24 (50.0) 110 (28.6) 2.1 (1.4-3.1) 2.6 (1.7-4.0) 1.1 (0.5-2.3)
Iatrogenic events (range, 0-24) 2.6 ± 2.9 3 ± 2.8 1.2 ± 1.6 1.2 (1.1-1.3)c 1.4 (1.2-1.5) 1.0 (0.8-1.1)
Any 46 (79.3) 41 (85.4) 218 (56.6) 2.5 (1.6-3.9)c 3.5 (2.1-6.0) 0.7 (0.2-1.8)
4 14 (24.1) 17 (35.4) 33 (8.6) 2.4 (1.5-3.9)c 4.4 (2.5-7.6) 0.6 (0.2-1.3)
Intercurrent illness
New diagnoses 2.7 ± 1.7 3.0 ± 1.8 2.1 ± 1.5 1.2 (1.1-1.3)c 1.3 (1.1-1.5) 0.9 (0.7-1.1)
Any new diagnosis 52 (89.7) 46 (95.8) 339 (88.1) 1.2 (0.6-2.4) 1.7 (0.8-3.6) 0.4 (0.1-2.0)
Hospital medications
3 Added in 1 day 35 (60.3) 35 (72.9) 203 (52.7) 1.3 (0.9-2.0)c 1.7 (1.1-2.7) 0.6 (0.2-1.3)
Total new medications 2.8 ± 2.9 4.0 ± 3.6 2.8 ± 2.3 1.0 (0.9-1.1)c 1.1 (1.0-1.2) 0.9 (0.8-1.0)
3 Psychoactive medications in 1 day 11 (19.0) 16 (33.3) 115 (29.9) 0.7 (0.5-1.1) 0.8 (0.5-1.3) 0.5 (0.2-1.1)
Abbreviations: ADL, activities of daily living34,35; APACHE II, Acute Physiology and Chronic Health Evaluation II39,40; CAM, Confusion Assessment Method33;
mBDRS, modified Blessed Dementia Rating Scale42,43; MMSE, Mini-Mental State Examination31; SUN-Cr, serum urea nitrogen–creatinine.
aEducation data were missing for 19 subjects; baseline MMSE score lower than 24 data missing for 6 subjects; serum urea nitrogen–creatinine ratio missing for
1 subject.
bData are reported as mean ± SD values or number (percentage) of subjects.
cFor these analyses, an interaction term indicated a significant difference between the 2 comparisons (any delirium vs no delirium and delirium at discharge vs
resolved delirium). None of these variables was included in the final model.
dFor the overall model, the at-risk period for defining risk factors was considered the delirium interval (ie, the inclusive days of delirium from the first day of
CAM-positive rating until discharge) for the delirium at discharge group, the period from delirium onset to resolution in the resolved delirium group, and the entire
hospitalization for the no delirium group.
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with a corresponding risk gradient extending from 1.0
(reference) to 4.4 to 15.3 (Table 4).
Validation Cohort
Of the 461 patients in the validation cohort, 63 devel-
oped delirium during hospitalization (13.7%), and me-
dian length of stay was 6 days (range, 3-60 days). Of the
28 patients with delirium that persisted to discharge
(6.1%), median time from admission to delirium onset
was 5 days (range, 2-52 days); median duration of de-
lirium in the hospital was 7 days (range, 1-26 days); and
median length of stay was 12 days (range, 4-53 days).
Of the 35 patients with resolved delirium, median time
from admission to delirium onset was 4 days (range, 2-10
days); median duration of delirium in the hospital was 2
days (range, 1-31 days); and median length of stay was
10 days (range, 3-60 days). Although the development
and validation cohorts were comparable in many base-
line characteristics, the validation cohort was signifi-
cantly older, hadmore cognitive impairment and higher
illness severity, and was less likely to be married or vi-
sually impaired (Table 1).
In the validation cohort, the predictive model yielded
a C statistic of 0.75. Applying the risk stratification sys-
tem (Table 4), we found that the rates of delirium at dis-
charge increased from 3% to 14% to 27% in low-, inter-
mediate-, and high-risk groups, respectively (2=28.77
for trend, P .001), representing a 10-fold increased risk
of delirium at discharge between the low- and high-risk
groups.
Clinical Outcomes Related to Delirium at Discharge
The predictive validity of the risk stratification system
was evaluated for prediction of death or nursing home
placement during 1-year follow-up (Table 5). The
hierarchical outcome of either death or nursing home
placement was chosen since the combination avoids
inferential errors that arise because patients who die
can no longer be institutionalized.62 In addition, a pre-
vious study demonstrated that delirium at discharge
was associated with increased rates of this hierarchical
outcome.23 In the development cohort, the rate of death
or nursing home placement increased from 23% to 57%
to 77% in the low-, intermediate-, and high-risk groups,
respectively, for a 3.4-fold increase overall (2=62.1 for
trend, P .001). In the validation cohort, the corre-
sponding rates increased from 15% to 39% to 64%, for a
4.4-fold increase overall (2=42.1 for trend, P .001).
COMMENT
We developed and successfully validated, in a separate,
clinically distinct sample, a predictive model for de-
lirium persisting to hospital discharge based on 5 inde-
pendent risk factors: dementia, vision impairment, func-
tional impairment, high comorbidity, and use of physical
restraints during delirium. Four of these factorswere base-
line factors, a finding that highlights the predominance
of vulnerability or impaired cognitive reserve contribut-
ing to delirium at discharge and reinforces the impor-
tance of preventive approaches. Physical restraint use dur-
ing deliriumwas the only hospital-related factor to emerge
as a significant predictor. The association of physical re-
straint usewith persistent delirium is not surprising, given
the documented association of restraint use with inci-
dent delirium26 and its numerous adverse effects, includ-
ing increased agitation, immobility, functional decline,
incontinence, pressure ulcers, asphyxiation, and car-
diac arrest.63-65 The present findings—that physical re-
straints may prolong delirium and worsen clinical out-
comes—strongly indicate that physical restraints should
not be used for older persons with delirium. While the
prevalence of restraint use decreased over time between
the 2 study cohorts—from 15% in the development co-
hort to 2% in the validation cohort—the association of
restraint use with persistent delirium remained strong in
both. Recent reports indicate an average rate of restraint
Table 3. Independent Risk Factors for Delirium at Discharge
in 491 Subjects
Risk Factor
Adjusted OR
(95% CI)a
Dementia, by diagnosis or mBDRS 4
(n=96)
2.3 (1.4-3.7)
Vision impairment (n=189) 2.1 (1.3-3.2)
ADL impairment 1 (n=97) 1.7 (1.2-3.0)
Charlson score41 4 (n=140) 1.7 (1.1-2.6)
Restraint use during delirium (n=75) 3.2 (1.9-5.2)
Abbreviations: ADL, activities of daily living34,35; CI, confidence interval;
mBDRS, modified Blessed Dementia Rating Scale42,43; OR, odds ratio.
aAdjusted ORs derived from overall multivariable continuation ratio model
analysis.
Table 4. Performance of the Predictive Model in the 2 Cohorts
Risk Group
(Risk Factors, No.)
Cohort
Development Validation
Delirium at Dischargea RR (95% CI) Delirium at Dischargea RR (95% CI)
Low (0-1) 13/319 (4.1)b 1 [Reference] 9/338 (2.7)c 1 [Reference]
Intermediate (2-3) 25/140 (17.9)b 4.4 (2.3-8.3) 16/112 (14.3)c 5.4 (2.4-11.8)
High (4-5) 20/32 (62.5)b 15.3 (8.4-27.8) 3/11 (27.3)c 10.2 (3.2-32.7)
Abbreviations: CI, confidence interval; RR, relative risk.
aData are reported as number of applicable subjects/total number of subjects in the group (percentage).
b2=87.64 for trend, P .001.
c2=28.77 for trend, P .001.
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use of approximately 5% across 40 geographically di-
verse acute care hospitals and no change in restraint rates
between 1998 and 2005.66-68 Moreover, currently, there
are concerns about a potential resurgence of restraint use
in acute care facilities attributable to nursing shortages,
budgetary cutbacks, and decreased availability of alter-
natives such as sitters.
Previous studies have focused on outcomes related to
persistent delirium.3-9 Only 1 study to our knowledge has
examined risk factors for delirium persistence8 in pa-
tients with delirium entering a post–acute care setting.
Thus, our study is unique, to our knowledge, in evalu-
ating risk factors for persistence in patients with inci-
dent delirium and for separately examining risk factors
for delirium onset and persistence.
In contrast to our a priori hypothesis, we did not dis-
cover different risk factors contributing to delirium that
resolves vs persistent delirium. Baseline risk factors were
qualitatively similar but differed in their magnitudes of
association. Somewhat stronger relative risks were dem-
onstrated for delirium that resolves than for persistent
delirium. For hospital-related factors other than physi-
cal restraints, many factors were predictive of delirium
that resolves but did not predict persistent delirium.
The analyses of the hospital-related factors pre-
sentedmany challenges, including differing exposure pe-
riods between delirium and nondelirium groups, mul-
tiple potential factors (eg, diagnoses ormedications) that
were too varied to examine individually, and limited
power. Thus, important associationsmay have been over-
looked. Moreover, the protective ORs demonstrated for
some factors such as iatrogenic events raises the possi-
bility that these factors,while precipitating delirium,might
also heighten the recognition of delirium and thus lead
to its treatment and diminished persistence. Future stud-
ies will be needed to confirm this possibility.
Strengths of this study include the frequent, system-
atic assessment for delirium using a validated instru-
ment and the prospective collection of detailed risk-
factor information. The validation of the predictivemodel
in an independent cohort is another important strength.
The 2 cohorts demonstrated significant differences in
baseline characteristics and delirium rates; therefore,
the finding that the predictive model works well in both
cohorts lends support for its robustness and generaliz-
ability.27 Finally, the demonstration of the predictive
validity of the model for the clinically relevant outcome
of death or nursing home placement is another note-
worthy strength.
Several caveats deserve comment. The numbers of pa-
tients with delirium at discharge were relatively low, lim-
iting our power to examine a large number of potential
factors in our model. While the axis approach we chose
is well accepted, we recognize that alternative ap-
proaches may have been used for variable reduction. In
addition,methodologic constraints and small sample sizes
limited our ability to examinemany hospital-related fac-
tors. The differing at-risk periods across the study groups,
which included the entire hospitalization period for the
no delirium group, may have tended to bias the results
against finding a significant association in hospital-
related factors. The shift in themagnitude of the ORs be-
tween any delirium and persistent delirium ismost likely
due to measurement issues (such as the difficulty in
matching the at-risk periods). Finally, despite the vali-
dation of our predictive model in 1 independent sample,
future studies will be needed to verify its usefulness in
other populations.
Identifying risk factors is the critical first step in de-
veloping effective preventive strategies. Four of the iden-
tified risk factors are amenable to intervention.46 Persis-
tent delirium in patients with dementia may respond to
orientation procedures and therapeutic activities.46 Vi-
sion impairment may be improved with adaptive de-
vices, magnifying lenses, and improved lighting. Func-
tional impairment may respond to exercise andmobility
interventions. Avoidance of physical restraints in deliri-
ous patients may help to prevent persistence. Finally, the
model identifies patients at intermediate to high risk for
persistent delirium who would be appropriate candi-
dates for intervention strategies. Given the high preva-
lence and poor outcomes of persistent delirium in the
older population, this study paves the way for targeted
intervention trials to address this important problem.
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